Question 1

Does UBS Group own AXSM stock?

Accepted Answer

Yes. As of its Q2 2026 13F, UBS Group holds 151,903 shares of AXSM (Axsome Therapeutics), worth $37.2M.

Question 2

How many shares of AXSM does UBS Group own?

Accepted Answer

As of its Q2 2026 13F, UBS Group holds 151,903 shares of AXSM (Axsome Therapeutics).

Question 3

What is UBS Group's AXSM position worth?

Accepted Answer

As of its Q2 2026 13F, UBS Group's AXSM position is worth $37.2M.

Question 4

Is UBS Group buying or selling AXSM?

Accepted Answer

In Q2 2026, UBS Group reduced its AXSM position by 395,292 shares (-72.2%).

Question 5

When did UBS Group first buy AXSM?

Accepted Answer

UBS Group already held AXSM in its Q1 2019 13F, the earliest on record, and has listed it in 30 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	151,903	-72.2%	$37.2M	0.0%	$244.77	0
2026-Q1	Increased	547,195	+54.0%	$92.5M	0.0%	$169.02	42
2025-Q4	Increased	355,318	+67.3%	$64.9M	0.0%	$182.64	44
2025-Q3	Decreased	212,451	-64.3%	$25.8M	0.0%	$121.45	0
2025-Q2	Increased	595,455	+106.3%	$62.2M	0.0%	$104.39	48
2025-Q1	Increased	288,647	+95.9%	$33.7M	0.0%	$116.63	46
2024-Q4	Increased	147,347	+208.5%	$12.5M	0.0%	$84.61	45
2024-Q3	Increased	47,762	+20.3%	$4.3M	0.0%	$89.87	32